KRT-232
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for KRT-232, covering 2020-07-31 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia [Phase 1]